The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PSMT, MBNKF, HL and RMED
Globe Newswire

NEW YORK, June 18, 2019 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

PriceSmart, Inc. (NASDAQGS: PSMT)
Class Period: October 26, 2017 to October 25, 2018
Lead Plaintiff Deadline: July 22, 2019

During the class period, PriceSmart, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the Company’s omni-channel business strategy had failed to reach key operating goals; (2) the Company’s South America distribution strategy had failed to realize key cost saving goals; (3) the Company had invested Trinidad and Tobago dollars into certificates of deposits with financial institutions; (4) that these investments had been improperly classified as cash and cash equivalents; (5) the relevant corrections would materially impact financial statements; (6) there was a material weakness in the Company’s internal controls over financial reporting; (7) increasing competition negatively impacted the Company’s revenue and profitability; and (8) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Get additional information about the PSMT lawsuit: http://www.kleinstocklaw.com/pslra-1/pricesmart-inc-loss-submission-form?wire=3

Metro Bank PLC (OTCMKTS: MBNKF)
Class Period: March 6, 2018 to May 1, 2019
Lead Plaintiff Deadline: July 29, 2019

According to the complaint, Metro Bank PLC allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Metro Bank misclassified the risk terms of many of its loans; (2) accordingly, Metro Bank failed to maintain sufficient capital; (3) this conduct would lead to investigations by the PRA and FCA; (4) this conduct would also lead to the reduction of deposits at Metro Bank from larger commercial and partnership clients; and (5) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

Get additional information about the MBNKF lawsuit: http://www.kleinstocklaw.com/pslra-1/metro-bank-plc-loss-submission-form?wire=3

Hecla Mining Company (NYSE: HL)
Class Period: March 19, 2018 to May 8, 2019
Lead Plaintiff Deadline: July 23, 2019

The complaint alleges that throughout the class period Hecla Mining Company made materially false and/or misleading statements and/or failed to disclose that: (a) the Nevada operations were hemorrhaging cash due to a multitude of material problems identified by Defendants during Hecla’s extensive due diligence of the Nevada mines before the Class Period, and (b) as a result of these material problems, Defendants had no reasonable basis for their representations that the Nevada operations would be in a position to have positive or self-funding cash flow.

Get additional information about the HL lawsuit: http://www.kleinstocklaw.com/pslra-1/hecla-mining-company-loss-submission-form?wire=3

Ra Medical Systems, Inc. (NYSE: RMED)
Class Period: stockholders that purchased Ra Medical securities pursuant and/or traceable to the Company’s September 2018 initial public offering.
Lead Plaintiff Deadline: August 6, 2019

The complaint alleges Ra Medical Systems, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company’s evaluation of sales personnel candidates was inadequate; (2) the Company’s training program for sales personnel was inadequate; (3) as a  result,  the  Company  could  not  reasonably  assure  that  its  newly  hired  sales  personnel  were  adequately  experienced;  (4) as  a  result,  the  Company  would  suffer a shortage of qualified sales personnel; (5) the Company’s manufacturing process  could  not  reasonably  support  increased  catheter  production;  (6) as  a  result, the Company would suffer production delays; and (7) as a result of the foregoing,   Defendants’   positive   statements   about   the   Company’s   business,   operations,  and  prospects,  were  materially  misleading  and/or  lacked  a  reasonable  basis.

Get additional information about the RMED lawsuit: http://www.kleinstocklaw.com/pslra-1/ra-medical-systems-inc-loss-submission-form?wire=3

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

Primary Logo

 Top of page